Skip to main content
OpenTrials
Completed

NCT Number: NCT00380523

Analgesic Treatment Mediated by Arcoxia (0663-093)

Allow physicians to test the efficacy of arcoxia in patients with acute pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of acute pain susceptible of pharmacological treatment
  • Greater than 18 years of age
  • Voluntary acceptance to participate in the study and signature of the informed consent form

Exclusion criteria

  • Allergy to etoricoxib or any of its components
  • Less than 18 years old
  • Patient is taking anticoagulants
  • Patient that already has taken any drug as analgesic

Treatment and study plan

MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days

Drug

Primary outcomes

  1. Evaluate pain using the verbal analog scale (evaluate pain before starting treatment and then evaluate pain every day after had taken arcoxia up to three days)

Secondary outcomes

  1. Patient satisfaction with the drug therapy using PGART scale

  2. Patient satisfaction was obtained at the end of treatment(on third day)

Sponsors and collaborators

Lead sponsor

Organon and Co

Industry

Registry information

Official study title

Analgesic Treatment Mediated by Arcoxia

Important dates

Study start
2005
Primary completion
2005
Study completion
2005
First posted
Sep 26, 2006
Registry last updated
Feb 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.